Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease

Nature Reviews Neurology

Volumn 6, Issue 9, 2010, Pages 487-498

  Volkmann, Jens ^a   Daniels, Christine ^b   Witt, Karsten ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MOOD STABILIZER; NEUROLEPTIC AGENT; PRAMIPEXOLE;

ANXIETY; APATHY; BASAL GANGLION; BEHAVIOR CHANGE; BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DOPAMINE DYSREGULATION SYNDROME; DRUG DOSE INCREASE; DYSKINESIA; EUPHORIA; HUMAN; HYPOMANIA; IMPULSE CONTROL DISORDER; MANIA; MENTAL PERFORMANCE; NERVE CELL NETWORK; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; PUNDING; REVIEW; SUBTHALAMIC NUCLEUS; SUICIDE;

ANIMALS; DEEP BRAIN STIMULATION; HUMANS; NERVE NET; NEUROPSYCHIATRY; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 77956343472     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.111     Document Type: Review

References (111)

1. Deuschl, G. et al. A randomized trial of deepbrain stimulation for Parkinsons disease. N. Engl. J. Med. 355, 896-908 (2006).
2. Weaver, F. M. et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301, 63-73 (2009).
3. Voon, V., Kubu, C., Krack, P., Houeto, J. L. & Troster, A. i. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov. Disord. 21 (Suppl. 14), S305-S327 (2006).
4. Parsons, T. D., rogers, S. A., Braaten, A. J., Woods, S. P. & Troster, A. i. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinsons disease: a meta-analysis. Lancet Neurol. 5, 578-588 (2006).
5. Temel, Y. et al. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat. Disord. 12, 265-272 (2006).
6. Witt, K. et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinsons disease: a randomised, multicentre study. Lancet Neurol. 7, 605-614 (2008).
7. Deuschl, G. et al. Deep brain stimulation: postoperative issues. Mov. Disord. 21 (Suppl. 14), S219-S237 (2006).
8. Wilson, S., Bladin, P. & Saling, M. The "burden of normality": concepts of adjustment after surgery for seizures. J. Neurol. Neurosurg. Psychiatry 70, 649-656 (2001).
9. DeLong, M. R. & Wichmann, T. Circuits and circuit disorders of the basal ganglia. Arch. Neurol. 64, 20-24 (2007).
10. Parent, A. & Hazrati, L. N. Functional anatomy of the basal ganglia. ii. The place of subthalamic nucleus and exteral pallidum in basal ganglia circuity. Brain Res. Rev. 20, 128-154 (1995).
11. Nambu, A., Tokuno, H. & Takada, M. Functional significance of the cortico-subthalamo-pallidal hyperdirect pathway. Neurosci. Res. 43, 111-117 (2002).
12. Alexander, G. e. & Crutcher, M. D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266-271 (1990).
13. Alexander, G. e., Crutcher, M. D. & DeLong, M. r. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog. Brain Res. 85, 119-146 (1990).
14. Bevan, M. D., Atherton, J. F. & Baufreton, J. Cellular principles underlying normal and pathological activity in the subthalamic nucleus. Curr. Opin. Neurobiol. 16, 621-628 (2006).
15. Romanelli, P., Esposito, V., Schaal, D. W. & Heit, G. Somatotopy in the basal ganglia: experimental and clinical evidence for segregated sensorimotor channels. Brain Res. Brain Res. Rev. 48, 112-128 (2005).
16. Frank, M. J. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. J. Cogn. Neurosci. 17, 51-72 (2005).
17. Frank, M. J. Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making. Neural Netw. 19, 1120-1136 (2006).
18. Schultz, W. Behavioral dopamine signals. Trends Neurosci. 30, 203-210 (2007).
19. Frank, M. J., Samanta, J., Moustafa, A. A. & Sherman, S. J. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 318, 1309-1312 (2007).
20. DeLong, M. r. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285 (1990).
21. Bergman, H., Wichmann, T. & DeLong, M. R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249, 1436-1438 (1990).
22. Marsden, C. D. & Obeso, J. A. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinsons disease. Brain 117, 877-897 (1994).
23. Bar-Gad, i., Havazelet-Heimer, G., Goldberg, J. A., ruppin, e. & Bergman, H. reinforcement-driven dimensionality reduction-a model for information processing in the basal ganglia. J. Basic Clin. Physiol. Pharmacol. 11, 305-320 (2000).
24. Hammond, C., Bergman, H. & Brown, P. Pathological synchronization in Parkinsons disease: networks, models and treatments. Trends Neurosci. 30, 357-364 (2007).
25. Fearnley, J. M. & Lees, A. J. Ageing and Parkinsons disease: substantia nigra regional selectivity. Brain 114, 2283-2301 (1991).
26. Voon, V. et al. Chronic dopaminergic stimulation in Parkinsons disease: from dyskinesias to impulse control disorders. Lancet Neurol. 8, 1140-1149 (2009).
27. evans, A. H. et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann. Neurol. 59, 852-858 (2006).
28. Voon, V. et al. Mechanisms underlying dopaminemediated reward bias in compulsive behaviors. Neuron 65, 135-142 (2010).
29. Chaudhuri, K. r. & Schapira, A. H. Non-motor symptoms of Parkinsons disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 8, 464-474 (2009).
30. Muslimovic, D., Post, B., Speelman, J. D. & Schmand, B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65, 1239-1245 (2005).
31. Muslimovic, D., Post, B., Speelman, J. D., De Haan, r. J. & Schmand, B. Cognitive decline in Parkinsons disease: a prospective longitudinal study. J. Int. Neuropsychol. Soc. 15, 426-437 (2009).
32. Kulisevsky, J. role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinsons disease. Drugs Aging 16, 365-379 (2000).
33. Woods, S. P. et al. Statistical power of studies examining the cognitive effects of subthalamic nucleus deep brain stimulation in Parkinsons disease. Clin. Neuropsychol. 20, 27-38 (2006).
34. Alegret, M. et al. effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch. Neurol. 58, 1223-1227 (2001).
35. Daniele, A. et al. Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinsons disease. J. Neurol. Neurosurg. Psychiatry 74, 175-182 (2003).
36. Dujardin, K., Defebvre, L., Krystkowiak, P., Blond, S. & Destée, A. influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinsons disease. J. Neurol. 248, 603-611 (2001).
37. Morrison, C. e. et al. Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinsons disease. Arch. Clin. Neuropsychol. 19, 165-181 (2004).
38. Smeding, H. M. et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 66, 1830-1836 (2006).
39. Trepanier, L. L., Kumar, r., Lozano, A. M., Lang, A. e. & Saint-Cyr, J. A. Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinsons disease. Brain Cogn. 42, 324-347 (2000).
40. Zahodne, L. B. et al. Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinsons disease: a controlled study using reliable change. Clin. Neuropsychol. 23, 385-405 (2009).
41. Saint-Cyr, J. A., Trepanier, L. L., Kumar, r., Lozano, A. M. & Lang, A. e. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinsons disease. Brain 123, 2091-2108 (2000).
42. Alegret, M. et al. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinsons disease. Mov. Disord. 19, 1463-1469 (2004).
43. Ardouin, C. et al. Bilateral subthalamic or pallidal stimulation for Parkinsons disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann. Neurol. 46, 217-223 (1999).
44. Pillon, B. et al. Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinsons disease. Neurology 55, 411-418 (2000).
45. Aybek, S. et al. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinsons disease. Mov. Disord. 22, 974-981 (2007).
46. Smeding, H. M., Speelman, J. D., Huizenga, H. M., Schuurman, P. r. & Schmand, B. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson disease. J. Neurol. Neurosurg. Psychiatry doi:10.1136/jnnp.2007. 140012.
47. Uc, e. Y. et al. incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology 73, 1469-1477 (2009).
48. Kempster, P. A. et al. Patterns of levodopa response in Parkinsons disease: a clinicopathological study. Brain 130, 2123-2128 (2007).
49. Kempster, P. A., OSullivan, S. S., Holton, J. L., revesz, T. & Lees, A. J. Relationships between age and late progression of Parkinsons disease: a clinico-pathological study. Brain 133, 1755-1762 (2010).
50. York, M. K., Wilde, e. A., Simpson, r. & Jankovic, J. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J. Neurol. Sci. 287, 159-171 (2009).
51. Pedersen, K. F., Alves, G., Aarsland, D. & Larsen, J. P. Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J. Neurol. Neurosurg. Psychiatry 80, 1279-1282 (2009).
52. Jahanshahi, M. et al. The impact of deep brain stimulation on executive function in Parkinsons disease. Brain 123, 1142-1154 (2000).
53. Schroeder, U. et al. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PeT study. Brain 125, 1995-2004 (2002).
54. Witt, K. et al. Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson disease. Arch. Neurol. 61, 697-700 (2004).
55. Campbell, M. C. et al. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia 46, 3162-3169 (2008).
56. Baunez, C. & Robbins, T. W. Bilateral lesions of the subthalamic nucleus induce multiple deficits in an attentional task in rats. Eur. J. Neurosci. 9, 2086-2099 (1997).
57. eagle, D. M. & Baunez, C. is there an inhibitory-response-control system in the rat? evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci. Biobehav. Rev. 34, 50-72 (2010).
58. Carter, C. S. et al. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 280, 747-749 (1998).
59. Aron, A. r., Behrens, T. e., Smith, S., Frank, M. J. & Poldrack, r. A. Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (Mri) and functional Mri. J. Neurosci. 27, 3743-3752 (2007).
60. Aron, A. r. & Poldrack, r. A. Cortical and subcortical contributions to stop signal response inhibition: role of the subthalamic nucleus. J. Neurosci. 26, 2424-2433 (2006).
61. Li, C. S., Yan, P., Sinha, r. & Lee, T. W. Subcortical processes of motor response inhibition during a stop signal task. Neuroimage 41, 1352-1363 (2008).
62. ray, N. J. et al. The role of the subthalamic nucleus in response inhibition: evidence from deep brain stimulation for Parkinsons disease. Neuropsychologia 47, 2828-2834 (2009).
63. van den Wildenberg, W. P. et al. Stimulation of the subthalamic region facilitates the selection and inhibition of motor responses in Parkinsons disease. J. Cogn. Neurosci. 18, 626-636 (2006).
64. Ballanger, B. et al. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann. Neurol. 66, 817-824 (2009).
65. Witt, K., Kopper, F., Deuschl, G. & Krack, P. Subthalamic nucleus influences spatial orientation in extra-personal space. Mov. Disord. 21, 354-361 (2006).
66. Appleby, B. S., Duggan, P. S., regenberg, A. & rabins, P. V. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years experience. Mov. Disord. 22, 1722-1728 (2007).
67. Mallet, L. et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc. Natl Acad. Sci. USA 104, 10661-10666 (2007).
68. Herzog, J. et al. Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinsons disease. Mov. Disord. 18, 1382-1384 (2003).
69. Mandat, T. S., Hurwitz, T. & Honey, C. r. Hypomania as an adverse effect of subthalamic nucleus stimulation: report of two cases. Acta Neurochir. (Wien) 148, 895-897 (2006).
70. Raucher-Chene, D., Charrel, C. L., de Maindreville, A. D. & Limosin, F. Manic episode with psychotic symptoms in a patient with Parkinsons disease treated by subthalamic nucleus stimulation: improvement on switching the target. J. Neurol. Sci. 273, 116-117 (2008).
71. Coenen, V. A. et al. Medial forebrain bundle stimulation as a pathophysiological mechanism for hypomania in subthalamic nucleus deep brain stimulation for Parkinsons disease. Neurosurgery 64, 1106-1114 (2009).
72. Waraczynski, M. A. The central extended amygdala network as a proposed circuit underlying reward valuation. Neurosci. Biobehav. Rev. 30, 472-496 (2006).
73. Funkiewiez, A. et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinsons disease. Mov. Disord. 18, 524-530 (2003).
74. Bejjani, B. P. et al. Levodopa-induced dyskinesias in Parkinsons disease: is sensitization reversible? Ann. Neurol. 47, 655-658 (2000).
75. Berney, A. et al. Effect on mood of subthalamic DBS for Parkinsons disease: a consecutive series of 24 patients. Neurology 59, 1427-1429 (2002).
76. Houeto, J. L. et al. Behavioural disorders, Parkinsons disease and subthalamic stimulation. J. Neurol. Neurosurg. Psychiatry 72, 701-707 (2002).
77. Reijnders, J. S., Ehrt, U., Weber, W. E., Aarsland, D. & Leentjens, A. F. A systematic review of prevalence studies of depression in Parkinsons disease. Mov. Disord. 23, 183-189 (2008).
78. Castelli, L. et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinsons disease: effects on cognition, mood, anxiety and personality traits. Eur. Neurol. 55, 136-144 (2006).
79. Krack, P. et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinsons disease. N. Engl. J. Med. 349, 1925-1934 (2003).
80. Kaiser, i., Kryspin-exner, i., Brucke, T., Volc, D. & Alesch, F. Long-term effects of STN DBS on mood: psychosocial profiles remain stable in a 3-year follow-up. BMC Neurol. 8, 43 (2008).
81. Voon, V., Moro, e., Saint-Cyr, J. A., Lozano, A. M. & Lang, A. e. Psychiatric symptoms following surgery for Parkinsons disease with an emphasis on subthalamic stimulation. Adv. Neurol. 96, 130-147 (2005).
82. Witt, K. et al. Differential effects of l-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinsons disease. J. Neuropsychiatry Clin. Neurosci. 18, 397-401 (2006).
83. Tommasi, G. et al. Transient acute depressive state induced by subthalamic region stimulation. J. Neurol. Sci. 273, 135-138 (2008).
84. Bejjani, B. P. et al. Transient acute depression induced by high-frequency deep-brain stimulation. N. Engl. J. Med. 340, 1476-1480 (1999).
85. Okun, M. S. et al. Cognition and mood in Parkinsons disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPAre trial. Ann. Neurol. 65, 586-595 (2009).
86. Schneider, F. et al. Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease. Arch. Gen. Psychiatry 60, 296-302 (2003).
87. Maricle, r. A., Nutt, J. G., Valentine, r. J. & Carter, J. H. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinsons disease: a double-blind, placebocontrolled study. Neurology 45, 1757-1760 (1995).
88. Biseul, i. et al. Fear recognition is impaired by subthalamic nucleus stimulation in Parkinsons disease. Neuropsychologia 43, 1054-1059 (2005).
89. Vicente, S. et al. Subthalamic nucleus stimulation affects subjective emotional experience in Parkinsons disease patients. Neuropsychologia 47, 1928-1937 (2009).
90. Aarsland, D. et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinsons disease. J. Neurol. Neurosurg. Psychiatry 80, 928-930 (2009).
91. Bodi, N. et al. reward-learning and the noveltyseeking personality: a between-and withinsubjects study of the effects of dopamine agonists on young Parkinsons patients. Brain 132, 2385-2395 (2009).
92. Rylander, G. Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr. Neurol. Neurochir. 75, 203-212 (1972).
93. Evans, A. H. et al. Punding in Parkinsons disease: its relation to the dopamine dysregulation syndrome. Mov. Disord. 19, 397-405 (2004).
94. Weintraub, D. Dopamine and impulse control disorders in Parkinsons disease. Ann. Neurol. 64 (Suppl. 2), S93-S100 (2008).
95. Romito, L. M. et al. Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinsons disease. Mov. Disord. 17, 1371-1374 (2002).
96. Witt, K., Krack, P. & Deuschl, G. Change in artistic expression related to subthalamic stimulation. J. Neurol. 253, 955-956 (2006).
97. Smeding, H. M. et al. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J. Neurol. Neurosurg. Psychiatry 78, 517-519 (2007).
98. Ardouin, C. et al. Pathological gambling in Parkinsons disease improves on chronic subthalamic nucleus stimulation. Mov. Disord. 21, 1941-1946 (2006).
99. Lim, S. Y. et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinsons disease. J. Clin. Neurosci. 16, 1148-1152 (2009).
100. Soulas, T. et al. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinsons disease. J. Neurol. Neurosurg. Psychiatry 79, 952-954 (2008).
101. Voon, V. et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinsons disease. Brain 131, 2720-2728 (2008).
102. Rodrigues, A. M. et al. Suicide attempts after subthalamic nucleus stimulation for Parkinsons disease. Eur. Neurol. 63, 176-179 (2010).
103. Myslobodsky, M., Lalonde, F. M. & Hicks, L. Are patients with Parkinsons disease suicidal? J. Geriatr. Psychiatry Neurol. 14, 120-124 (2001).
104. Frank, M. J., Seeberger, L. C. & Oreilly, r. C. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306, 1940-1943 (2004).
105. Funkiewiez, A. et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinsons disease. J. Neurol. Neurosurg. Psychiatry 75, 834-839 (2004).
106. Pluck, G. C. & Brown, r. G. Apathy in Parkinsons disease. J. Neurol. Neurosurg. Psychiatry 73, 636-642 (2002).
107. Chatterjee, A. & Fahn, S. Methylphenidate treats apathy in Parkinsons disease. J. Neuropsychiatry Clin. Neurosci. 14, 461-462 (2002).
108. Marin, r. S., Fogel, B. S., Hawkins, J., Duffy, J. & Krupp, B. Apathy: a treatable syndrome. J. Neuropsychiatry Clin. Neurosci. 7, 23-30 (1995).
109. Drapier, D. et al. Does subthalamic nucleus stimulation induce apathy in Parkinsons disease? J. Neurol. 253, 1083-1091 (2006).
110. Le Jeune, F. et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PeT study. Neurology 73, 1746-1751 (2009).
111. Czernecki, V. et al. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinsons disease? J. Neurol. Neurosurg. Psychiatry 76, 775-779 (2005).